Skip to main content
. 2012 Oct 23;5(1):348–354. doi: 10.3892/ol.2012.987

Figure 2.

Figure 2

Cell viability of HepG2 cells and HUVECs. (A) HUVECs were infected with 10 MOI or 50 MOI Ad-E recombinant viruses for 24, 48 or 72 h. (B) HepG2 cells were infected with 10 MOI or 50 MOI Ad-T recombinant viruses for 24, 48 or 72 h. HUVEC, human umbilical vein endothelial cell; MOI, multiplicity of infection.